Literature DB >> 22882695

The pathogenesis of acute allograft dysfunction in desensitized renal transplant recipients.

N Singh1, Q Sun, T Nadasdy, P Adams, N R Dipaola, T Pesavento, H Winters, A Satoskar, Z Yu, M Henry, G A Hadley, R P Pelletier.   

Abstract

BACKGROUND: Acute allograft rejection after HLA desensitization is common early post-transplant but the sequence of histopathologic changes leading to graft dysfunction has not been well defined.
METHODS: We evaluated the early pathogenesis and sequence of antibody-mediated graft damage of 35 desensitized living donor kidney recipients by studying the course of biopsies taken in the very early post-transplant period (<1 month).
RESULTS: A total of 14 of the 35 patients met criteria for acute antibody-mediated rejection (AMR). In these patients, the chronologic sequence of pathologic changes was C4d peritubular capillary deposition, acute tubular injury, and peritubular capillaritis, followed by glomerulitis and interstitial inflammation. Classic AMR lesions occurred early, followed by mononuclear cellular infiltration, which comprised CD4 and CD8 T cells and monocytes. Development of graft dysfunction in most patients occurred concurrently with the emergence of graft cellular infiltration, rather than at the earlier time of antibody deposition as detected via C4d deposition.
CONCLUSION: These data provide novel insight into the sequence of pathologic changes in patients with AMR post-transplant after HLA desensitization.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22882695     DOI: 10.1111/j.1399-0012.2012.01684.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

1.  Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.

Authors:  A Gaughan; J Wang; R P Pelletier; T Nadasdy; S Brodsky; S Roy; M Lodder; D Bobek; S Mofatt-Bruce; R L Fairchild; M L Henry; G A Hadley
Journal:  Am J Transplant       Date:  2014-01-10       Impact factor: 8.086

Review 2.  Rational clinical trial design for antibody mediated renal allograft injury.

Authors:  Shaifali Sandal; Martin S Zand
Journal:  Front Biosci (Landmark Ed)       Date:  2015-01-01

Review 3.  Late and chronic antibody-mediated rejection: main barrier to long term graft survival.

Authors:  Qiquan Sun; Yang Yang
Journal:  Clin Dev Immunol       Date:  2013-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.